BlackRock
BCDA icon

BlackRock’s BioCardia BCDA Stock Holding History

BlackRock’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,059
Closed -$18.7K – 5284
2024
Q1 		$18.7K Buy
3,059
+208
+7% +$1.49K ﹤0.01% 5031
2023
Q4 		$28.4K Buy
2,851
+736
+35% +$5.97K ﹤0.01% 5040
2023
Q3 		$13.6K Sell
2,115
-86
-4% -$1.45K ﹤0.01% 5178
2023
Q2 		$88.1K Buy
+2,201
New +$67.8K ﹤0.01% 4957
2022
Q2 		– Sell
-2,295
Closed -$72K – 5852
2022
Q1 		$72K Sell
2,295
-113
-5% -$3.36K ﹤0.01% 5353
2021
Q4 		$70K Buy
2,408
+63
+3% +$2.31K ﹤0.01% 5356
2021
Q3 		$110K Sell
2,345
-50
-2% -$2.45K ﹤0.01% 5117
2021
Q2 		$143K Buy
+2,395
New +$145K ﹤0.01% 4968

Other funds holding BCDA

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock's BCDA Position: Q2 2024 in Review

BlackRock sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 3,059 shares — an estimated $18.7K sold.

BlackRock first reported a position in BCDA in Q2 2021 and held it in 8 quarters. The position peaked at $143K in Q2 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

  • BlackRock reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 3,059 BioCardia shares in Q2 2024, an estimated $18.7K.
  • BlackRock first reported a position in BioCardia in Q2 2021 and held it in 8 quarters.
  • BlackRock's BioCardia position peaked at $143K in Q2 2021.
  • 10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.